AbbVie (ABBV) Inventory (2012 - 2026)
AbbVie (ABBV) reported Inventory of $5.0 billion for Q1 2026, up 11.56% year-over-year from $4.5 billion in Q1 2025, and up 1.98% on a QoQ basis from $5.0 billion in Q4 2025.
AbbVie (ABBV) has 15 years of Inventory data on file, last reported at $5.0 billion in Q1 2026.
- Quarterly Inventory rose 11.56% year-over-year to $5.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.0 billion (up 11.56% YoY) and the FY2025 annual result came in at $5.0 billion, up 18.42% from the prior year.
- Inventory improved to $5.0 billion in Q1 2026 per ABBV's latest filing, from $5.0 billion in the prior quarter.
- Across five years, Inventory topped out at $5.0 billion in Q1 2026 and bottomed at $3.2 billion in Q3 2022.
- The 5-year median for Inventory is $4.2 billion (2024), against an average of $4.2 billion.
- The widest annual swing landed in 2022, when Inventory rose 0.3%; it then rose 25.5% in 2023.
- Tracing ABBV's Inventory over 5 years: stood at $3.6 billion in 2022, then climbed by 14.53% to $4.1 billion in 2023, then advanced by 2.0% to $4.2 billion in 2024, then increased by 18.42% to $5.0 billion in 2025, then increased by 1.98% to $5.0 billion in 2026.
- Per Business Quant, the three latest ABBV Inventory figures stand at $5.0 billion (Q1 2026), $5.0 billion (Q4 2025), and $4.9 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | -787.00 Mn |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 14.53 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 14.58 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 5.05 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 6.48 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 6.19 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 1.91 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 10.67 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 2.76 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 7.88 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.05 Bn |
| Dec 31, 2025 | 4.95 Bn |
| Sep 30, 2025 | 4.94 Bn |
| Jun 30, 2025 | 4.96 Bn |
| Mar 31, 2025 | 4.53 Bn |
| Dec 31, 2024 | 4.18 Bn |
| Sep 30, 2024 | 4.45 Bn |
| Jun 30, 2024 | 4.22 Bn |
| Mar 31, 2024 | 4.25 Bn |
| Dec 31, 2023 | 4.10 Bn |
| Sep 30, 2023 | 3.98 Bn |
| Jun 30, 2023 | 4.06 Bn |
| Mar 31, 2023 | 3.83 Bn |
| Dec 31, 2022 | 3.58 Bn |
| Sep 30, 2022 | 3.17 Bn |
| Jun 30, 2022 | 3.40 Bn |
| Mar 31, 2022 | 3.48 Bn |
| Dec 31, 2021 | 3.13 Bn |
| Sep 30, 2021 | 3.09 Bn |
| Jun 30, 2021 | 3.39 Bn |
| Mar 31, 2021 | 3.27 Bn |
| Dec 31, 2020 | 3.31 Bn |
| Sep 30, 2020 | 3.47 Bn |
| Jun 30, 2020 | 4.06 Bn |
| Mar 31, 2020 | 1.84 Bn |
| Dec 31, 2019 | 1.81 Bn |
| Sep 30, 2019 | 1.93 Bn |
| Jun 30, 2019 | 1.90 Bn |
| Mar 31, 2019 | 1.70 Bn |
| Dec 31, 2018 | 1.61 Bn |
| Sep 30, 2018 | 1.79 Bn |
| Jun 30, 2018 | 1.58 Bn |
| Mar 31, 2018 | 1.74 Bn |
| Dec 31, 2017 | 1.61 Bn |
| Sep 30, 2017 | 1.79 Bn |
| Jun 30, 2017 | 1.58 Bn |
| Mar 31, 2017 | 1.43 Bn |
| Dec 31, 2016 | 1.44 Bn |
| Sep 30, 2016 | 1.63 Bn |
| Jun 30, 2016 | 1.76 Bn |
| Mar 31, 2016 | 1.79 Bn |
| Dec 31, 2015 | 1.72 Bn |
| Sep 30, 2015 | 1.84 Bn |
| Jun 30, 2015 | 1.62 Bn |
| Mar 31, 2015 | 1.02 Bn |
| Dec 31, 2014 | 1.12 Bn |
| Sep 30, 2014 | 1.01 Bn |
| Jun 30, 2014 | 1.05 Bn |
| Mar 31, 2014 | 1.10 Bn |
| Dec 31, 2013 | 1.15 Bn |
| Sep 30, 2013 | 1.17 Bn |
| Jun 30, 2013 | 1.09 Bn |
| Mar 31, 2013 | 1.04 Bn |
| Dec 31, 2012 | 1.09 Bn |